Table 3.
Univariate and multivariate analyses for the evaluation of variables that predict the presence of EOC
| Univariate | Multivariate | ||||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| Age (years) (<65 vs. ≥65) | 4.39 (2.47, 8.18) | <0.001 | 4.14 (2.00, 8.90) | <0.001 | |
| WBC (per µL) (≤11000 vs. >11000) | 2.86 (1.27, 7.06) | 0.015 | |||
| Hemoglobin (g/dL) (≤12.0 vs. >12.0) | 0.42 (0.28, 0.64) | <0.001 | |||
| Platelets (×103 per µL) (≤400 vs. >400) | 7.93 (3.52, 21.26) | <0.001 | |||
| CA125 (unit/mL) (≤35 vs. >35) | 12.58 (8.26, 19.49) | <0.001 | 9.87 (6.27, 15.84) | <0.001 | |
| NLR (≤2.64 vs. >2.64) | 4.50 (3.06, 6.68) | <0.001 | 1.76 (1.00, 3.09) | 0.049 | |
| PLR (≤191.71 vs. >191.71) | 5.68 (3.70, 8.88) | <0.001 | 2.41 (1.34, 4.38) | 0.004 | |
| LMR (≤3.52 vs. >3.52) | 0.21 (0.14, 0.33) | <0.001 | 0.51 (0.28, 0.91) | 0.024 | |
Results of multiple logistic regression with variables show a P-value less than 0.05 in univariate regression.
EOC, epithelial ovarian cancer; OR, odds ratio; CI, confidence interval; WBC, white blood cell; CA125, cancer antigen 125; NLR, neutrophil-lymphocyte ratio; PLR, platelet-lymphocyte ratio; LMR, lymphocyte-monocyte ratio